1. Home
  2. MIRM
  3. MIRM News

Latest Mirum Pharmaceuticals Inc. (MIRM) News on June 2, 2025

This week in Trumponomics: Too bad TACO isn’t true
MIRM

Yahoo Finance

2 days ago

This week in Trumponomics: Too bad TACO isn’t true

Starmer says Farage would spook the City and give us Truss 2 – he could be right
MIRM

The Guardian

2 days ago

Starmer says Farage would spook the City and give us Truss 2 – he could be right

AI ecosystem isn't just Nvidia: Unlock it further with this ETF
MIRM

Yahoo Finance Video

2 days ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Ford recalls more than 29,000 vehicles in the US, NHTSA says
MIRM

Reuters

2 days ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states
MIRM

USA TODAY

2 days ago

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states

Here's Why We Think HBT Financial (NASDAQ:HBT) Is Well Worth Watching
MIRM

Simply Wall St.

2 days ago

Here's Why We Think HBT Financial (NASDAQ:HBT) Is Well Worth Watching

Saturday Sessions: OK Go performs "Love"
MIRM

CBS News Videos

2 days ago

Saturday Sessions: OK Go performs "Love"

We're Not Very Worried About Black Swan Graphene's (CVE:SWAN) Cash Burn Rate
MIRM

Simply Wall St.

2 days ago

We're Not Very Worried About Black Swan Graphene's (CVE:SWAN) Cash Burn Rate

Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer
MIRM

Business Wire

14 days ago

Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
MIRM

Business Wire

19 days ago

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

24 days ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL
MIRM

Business Wire

24 days ago

Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL

Mirum Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
MIRM

Simply Wall St.

24 days ago

Mirum Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Mirum's Q1 Earnings Beat Estimates, 2025 Revenue View Raised
MIRM

Zacks

25 days ago

Mirum's Q1 Earnings Beat Estimates, 2025 Revenue View Raised

MIRM

Thomson Reuters StreetEvents

25 days ago

Q1 2025 Mirum Pharmaceuticals Inc Earnings Call

MIRM

GuruFocus.com

25 days ago

Mirum Pharmaceuticals Inc (MIRM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Tops Revenue Estimates
MIRM

Zacks

a month ago

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Tops Revenue Estimates

Mirum Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
MIRM

Business Wire

a month ago

Mirum Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Tango Therapeutics, Inc. (TNGX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
MIRM

Zacks

a month ago

Tango Therapeutics, Inc. (TNGX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

High Growth Tech Stocks To Watch In The US May 2025
MIRM

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In The US May 2025

Mirum Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
MIRM

Business Wire

a month ago

Mirum Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

Mirum Pharmaceuticals to Present Data at Upcoming Medical Congresses
MIRM

Business Wire

a month ago

Mirum Pharmaceuticals to Present Data at Upcoming Medical Congresses

Rhythm Pharmaceuticals (RYTM) Moves 5.2% Higher: Will This Strength Last?
MIRM

Zacks

a month ago

Rhythm Pharmaceuticals (RYTM) Moves 5.2% Higher: Will This Strength Last?

MIRM

MT Newswires

2 months ago

Mirum Pharmaceuticals Says FDA Approves Tablet Formulation of Treatment for Cholestatic Pruritus

Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation
MIRM

Business Wire

2 months ago

Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

2 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock?
MIRM

Zacks

2 months ago

Avidity Biosciences (RNA) Soars 11.3%: Is Further Upside Left in the Stock?

Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound?
MIRM

Zacks

2 months ago

Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound?

MIRM

MT Newswires

2 months ago

Mirum Pharmaceuticals Says Livmarli Approved in Japan for Pruritus

LIVMARLI Now Approved in Japan for ALGS and PFIC
MIRM

Business Wire

2 months ago

LIVMARLI Now Approved in Japan for ALGS and PFIC

Exploring 3 High Growth Tech Stocks in the US Market
MIRM

Simply Wall St.

2 months ago

Exploring 3 High Growth Tech Stocks in the US Market

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

3 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIRM

MT Newswires

3 months ago

Mirum Pharmaceuticals Insider Sold Shares Worth $676,928, According to a Recent SEC Filing

Analyst Estimates: Here's What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report
MIRM

Simply Wall St.

3 months ago

Analyst Estimates: Here's What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report

Mirum Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
MIRM

Simply Wall St.

3 months ago

Mirum Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

MIRM

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Mirum Pharmaceuticals Inc Earnings Call

MIRM's Q4 Loss Wider Than Expected, Revenues Beat Estimates
MIRM

Zacks

3 months ago

MIRM's Q4 Loss Wider Than Expected, Revenues Beat Estimates

MIRM

GuruFocus.com

3 months ago

Mirum Pharmaceuticals Inc (MIRM) Q4 2024 Earnings Call Highlights: Record Sales Surge and ...

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
MIRM

Zacks

3 months ago

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
MIRM

Business Wire

3 months ago

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals (MIRM): Among the Best Performing Mid Cap Stocks to Buy According to Analysts
MIRM

Insider Monkey

3 months ago

Mirum Pharmaceuticals (MIRM): Among the Best Performing Mid Cap Stocks to Buy According to Analysts

Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know
MIRM

Zacks

3 months ago

Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know

MIRM

MT Newswires

3 months ago

Mirum Pharmaceuticals Says US FDA Approves Cerebrotendinous Xanthomatosis' Treatment Drug

Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
MIRM

Business Wire

3 months ago

Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)

Mirum drug for rare genetic disease gains FDA approval
MIRM

BioPharma Dive

3 months ago

Mirum drug for rare genetic disease gains FDA approval

MIRM

MT Newswires

3 months ago

Mirum Pharmaceuticals' Lipid Storage Disease Treatment Gets FDA Approval

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025
MIRM

Business Wire

3 months ago

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025

High Growth Tech Stocks in United States to Watch
MIRM

Simply Wall St.

3 months ago

High Growth Tech Stocks in United States to Watch

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

4 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIRM

MT Newswires

4 months ago

Mirum Pharmaceuticals Insider Sold Shares Worth $327,658, According to a Recent SEC Filing

Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock?
MIRM

Zacks

4 months ago

Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock?

MIRM

MT Newswires

4 months ago

Mirum Pharmaceuticals Insider Sold Shares Worth $319,598, According to a Recent SEC Filing

MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results
MIRM

Zacks

5 months ago

MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results

Exploring Three High Growth Tech Stocks in the United States
MIRM

Simply Wall St.

5 months ago

Exploring Three High Growth Tech Stocks in the United States

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?
MIRM

Zacks

5 months ago

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

Mirum Pharmaceuticals (MIRM) Is a Great Choice for 'Trend' Investors, Here's Why
MIRM

Zacks

5 months ago

Mirum Pharmaceuticals (MIRM) Is a Great Choice for 'Trend' Investors, Here's Why

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
MIRM

Business Wire

5 months ago

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

5 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIRM

MT Newswires

5 months ago

Mirum Pharmaceuticals Insider Sold Shares Worth $320,644, According to a Recent SEC Filing

Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
MIRM

Business Wire

5 months ago

Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Path To Profitability
MIRM

Simply Wall St.

5 months ago

Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Path To Profitability

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?
MIRM

Zacks

6 months ago

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

6 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals price target raised to $74 from $69 at JMP Securities
MIRM

TipRanks

6 months ago

Mirum Pharmaceuticals price target raised to $74 from $69 at JMP Securities

Mirum Shares Surge More Than 90% in 6 Months: Here's Why
MIRM

Zacks

6 months ago

Mirum Shares Surge More Than 90% in 6 Months: Here's Why

Analysts Are Updating Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates After Its Third-Quarter Results
MIRM

Simply Wall St.

7 months ago

Analysts Are Updating Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates After Its Third-Quarter Results

Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting
MIRM

Business Wire

7 months ago

Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting

Mirum Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
MIRM

Simply Wall St.

7 months ago

Mirum Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

MIRM

GuruFocus.com

7 months ago

Mirum Pharmaceuticals Inc (MIRM) Q3 2024 Earnings Call Highlights: Record Sales Surge and ...

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised
MIRM

Zacks

7 months ago

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q3 Loss, Tops Revenue Estimates
MIRM

Zacks

7 months ago

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q3 Loss, Tops Revenue Estimates

MIRM

MT Newswires

7 months ago

Mirum Pharmaceuticals' Q3 Loss Narrows, Revenue Rises

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
MIRM

Business Wire

7 months ago

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

7 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
MIRM

Business Wire

7 months ago

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

High Growth Tech Stocks In The United States To Watch
MIRM

Simply Wall St.

7 months ago

High Growth Tech Stocks In The United States To Watch

Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
MIRM

Business Wire

7 months ago

Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know
MIRM

Zacks

7 months ago

Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know

Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting
MIRM

Business Wire

7 months ago

Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting

Mirum Pharmaceuticals (MIRM): A Small-Cap Biotech with Strong Sales Growth
MIRM

Insider Monkey

7 months ago

Mirum Pharmaceuticals (MIRM): A Small-Cap Biotech with Strong Sales Growth

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

8 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIRM

MT Newswires

8 months ago

Mirum Pharmaceuticals Says Volixibat Gets FDA Breakthrough Therapy Designation in Cholestatic Pruritus

Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis
MIRM

Business Wire

8 months ago

Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis

MIRM

GuruFocus.com

8 months ago

Mirum Pharmaceuticals Inc (MIRM) Q2 2024 Earnings Call Highlights: Record Sales Surge and ...

Exploring High Growth Tech Stocks In The US October 2024
MIRM

Simply Wall St.

8 months ago

Exploring High Growth Tech Stocks In The US October 2024

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

9 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
MIRM

Investor's Business Daily

9 months ago

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up

Mirum Pharmaceuticals (MIRM) Up 4.5% Since Last Earnings Report: Can It Continue?
MIRM

Zacks

9 months ago

Mirum Pharmaceuticals (MIRM) Up 4.5% Since Last Earnings Report: Can It Continue?

High Growth Tech Stocks To Watch In August 2024
MIRM

Simply Wall St.

9 months ago

High Growth Tech Stocks To Watch In August 2024

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
MIRM

Business Wire

9 months ago

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

MIRM

MT Newswires

9 months ago

Evercore ISI Raises Price Target on Mirum Pharmaceuticals to $66 From $62, Keeps Outperform Rating

Mirum (MIRM) Banks on Livmarli, Overdependence a Concern
MIRM

Zacks

9 months ago

Mirum (MIRM) Banks on Livmarli, Overdependence a Concern

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
MIRM

Simply Wall St.

10 months ago

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

10 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum's (MIRM) Q2 Earnings Lag Estimates, Revenues Top
MIRM

Zacks

10 months ago

Mirum's (MIRM) Q2 Earnings Lag Estimates, Revenues Top

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates
MIRM

Zacks

10 months ago

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates

Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
MIRM

Business Wire

10 months ago

Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024
MIRM

Business Wire

10 months ago

Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024

Mirum Pharmaceuticals (MIRM) Surges 7.3%: Is This an Indication of Further Gains?
MIRM

Zacks

10 months ago

Mirum Pharmaceuticals (MIRM) Surges 7.3%: Is This an Indication of Further Gains?

MIRM

MT Newswires

10 months ago

Mirum Pharmaceuticals Gets FDA Label Expansion Approval for Liver Disease Treatment; Shares Jump

Share on Social Networks: